PIAI team

The UK will implement a Carbon Border Adjustment Mechanism (UK CBAM) in 2027. This guide explains the new UK carbon border tax, its scope, timeline, and key differences from the EU's regulation, helping businesses prepare for the new compliance landscape.

Keyword alerts create noise, not signal. Learn why proactive supply chain intelligence is essential for managing modern risks and building a resilient supply chain.

A practical guide for public affairs teams on how to monitor the EU Parliament's IMCO committee for CSDDD updates using social media. Learn to identify key actors, set up structured searches, and analyze signals to anticipate policy shifts.

Trade Policy · Stakeholder Mapping What is Stakeholder Mapping for Trade Policy? Stakeholder mapping for trade policy is the process of identifying, analyzing, and visualizing the influence of everyone involved in a trade agreement. It is a vital practice for public affairs, compliance, and strategy teams in international commerce. Without it, organizations react to news […]

A practical guide for UK pharma market access teams on how to effectively map stakeholders. Learn to identify, analyze, and engage key influencers from NICE and the MHRA to regional ICSs in a complex post-Brexit landscape.

This guide explains the EU Battery Regulation (EU) 2023/1542 for OEMs. We break down the five core pillars of compliance, including the Digital Battery Passport, supply chain due diligence, and carbon footprint rules, to help leaders ensure EU market access.

For UK businesses, the EU-Mercosur trade deal creates immediate tariff disadvantages but opens strategic post-Brexit opportunities. This analysis explores the competitive risks, the current status of the deal, and how UK firms can leverage agility to secure an advantage.

The EU's Carbon Border Adjustment Mechanism (CBAM) introduces a carbon tax on imports, creating significant financial risk for industrial portfolios. This guide explains what CBAM is, how it works, and provides a framework for PE & VC firms to assess and mitigate its impact on asset value.

Manual spreadsheets can't keep up with modern regulatory risk. Discover how an AI-powered risk intelligence platform enables automated compliance monitoring for PE firms, transforming unstructured public data into a proactive strategic advantage.

Navigate Japan's complex pharmaceutical market with our expert guide. Understand the core challenges of the MHLW-led drug pricing system, key repricing rules like Market Expansion Repricing, and major policy trends to watch.